Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis patents antisense oligonucleotides for cancer treatment

Dec. 7, 1998

FDA approves Hycamtin as second-line treatment of small cell lung cancer

Dec. 4, 1998

Maxia initiates pivotal phase III trial with MX-6 for treatment of CIN

Dec. 4, 1998

Accutin, an RGD-containing peptide with angiogenesis-inhibitory activity

Dec. 3, 1998

Adozelesin displays marginal efficacy in previously untreated metastatic breast cancer

Dec. 3, 1998

IntraBiotics receives milestone payment from Pharmacia & Upjohn

Dec. 3, 1998

Lack of cardiotoxicity of SM-5887 confirmed in dogs

Dec. 2, 1998

Taisho discloses new antitumor series

Dec. 2, 1998

Inhibitors of neovascularization (angiogenesis) patented by JT

Dec. 2, 1998

Vical reports delivery of cytokine and antitumor activity using naked DNA gene transfer

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...